New York Southern Bankruptcy Court

Case number: 7:23-bk-22414 - Endo Biologics Limited - New York Southern Bankruptcy Court

Case Information
Case title
Endo Biologics Limited
Chapter
11
Judge
James L. Garrity Jr.
Filed
05/31/2023
Last Filing
12/05/2024
Asset
Yes
Vol
v
Docket Header

MEGANY, MEGA, JtAdm, CLMAGT




U.S. Bankruptcy Court
Southern District of New York (White Plains)
Bankruptcy Petition #: 23-22414-jlg

Assigned to: Judge James L. Garrity Jr.
Chapter 11
Voluntary
Asset


Date filed:  05/31/2023

Debtor

Operand Pharmaceuticals II Limited

1400 Atwater Drive
Malvern, PA 19355
CHESTER-PA
Tax ID / EIN: XX-XXXXXXX
aka
Zoo Universal Pharmaceuticals II Limited


represented by
Lisa Laukitis

Skadden, Arps, Slate, Meagher & Flom LLP
One Manhattan West
New York, NY 10001-8602
212-735-3000
Fax : 212-735-2000
Email: [email protected]

Paul D. Leake

Skadden, Arps, Slate, Meagher & Flom LLP
One Manhattan West
New York, NY 10001
212-735-3000
Fax : 212-735-2000
Email: [email protected]

Kyle J. Ortiz

Togut, Segal & Segal LLP
One Penn Plaza
Suite 3335
New York, NY 10119
212-594-5000
Fax : 212-967-4258
Email: [email protected]

U.S. Trustee

United States Trustee

Office of the United States Trustee - NY
Alexander Hamilton Custom House
One Bowling Green, Room 534
New York, NY 10004-1408
(212) 510-0500

 
 
Claims and Noticing Agent

Kroll Restructuring Administration LLC Claims Agent

(Formerly Prime Clerk LLC)
55 East 52nd Street
17th Floor
www.kroll.com
New York, NY 10055
(212) 257-5450
 
 

Latest Dockets
Date Filed#Docket Text
07/17/2023Docket Text
Pending Deadlines Terminated: All Schedules and Statements.
(Rodriguez, Willie) (Entered: 07/17/2023)
07/14/20239Docket Text
Statement of Financial Affairs - Non-Individual /Global Notes and Statement of Financial Affairs for Operand Pharmaceuticals II Limited Filed by Kyle J. Ortiz on behalf of Operand Pharmaceuticals II Limited. (Ortiz, Kyle) (Entered: 07/14/2023)
07/14/20238Docket Text
Schedules filed: Schedule A/B - Non-Individual, Schedule D - Non-Individual, Schedule E/F - Non-Individual, Schedule G - Non-Individual, Schedule H - Non-Individual /Global Notes and Summary and Schedules of Assets and Liabilities for Operand Pharmaceuticals II Limited Filed by Kyle J. Ortiz on behalf of Operand Pharmaceuticals II Limited. (Ortiz, Kyle) (Entered: 07/14/2023)
07/06/20237Docket Text
Order signed on 7/6/2023 Granting Motion To Extend Deadline to File Schedules or Provide Required Information:
Deadline: 7/14/2023
(Related Doc # 3) (Rodriguez, Willie) (Entered: 07/06/2023)
07/06/2023Docket Text
Deficiencies Set: Schedule A/B due 6/14/2023. Schedule D due 6/14/2023. Schedule E/F due 6/14/2023. Schedule G due 6/14/2023. Schedule H due 6/14/2023. Summary of Assets and Liabilities due 6/14/2023. Statement of Financial Affairs due 6/14/2023. Incomplete Filings due by 6/14/2023, (Porter, Minnie). (Entered: 07/06/2023)
06/30/20236Docket Text
Transcript regarding Hearing Held on 6/22/2023 at 11:09 AM RE: Motion to Extend Deadline to File Schedules or Provide Required Information.
Remote electronic access to the transcript is restricted until 9/28/2023.
The transcript may be viewed at the Bankruptcy Court Clerks Office. [Transcription Service Agency: eScribers, LLC.]. (See the Courts Website for contact information for the Transcription Service Agency.) (RE: related document(s) 3). Notice of Intent to Request Redaction Deadline Due By 7/7/2023. Statement of Redaction Request Due By 7/21/2023. Redacted Transcript Submission Due By 7/31/2023. Transcript access will be restricted through 9/28/2023. (Ortiz, Carmen) (Entered: 06/30/2023)
06/20/20235Docket Text
Certificate of No Objection Pursuant to LR 9075-2 /Certificate of No Objection to Motion of the Debtors for Entry of an Order Extending Time to File Schedules of Assets and Liabilities and Statements of Financial Affairs for the Additional Debtors and Any Future Debtors Filed by Kyle J. Ortiz on behalf of Operand Pharmaceuticals II Limited. (Ortiz, Kyle) (Entered: 06/20/2023)
06/16/20234Docket Text
Disclosure of Compensation of Attorney For Debtor (Rule 2016(b))- Form 2030 Filed by Lisa Laukitis on behalf of Operand Pharmaceuticals II Limited. (Laukitis, Lisa) (Entered: 06/16/2023)
06/08/2023Docket Text
Claims and Noticing Agent, Kroll Restructuring Administration LLC, added to the case. (Rodriguez, Willie). (Entered: 06/08/2023)
06/08/2023Docket Text
Case Jointly Administrated with Case # 22-22549 per Order signed on 8/17/2023 in Case # 22-22549 Doc # 45.
(Rodriguez, Willie) (Entered: 06/08/2023)